San Diego, CA, United States of America

Christine Dugovic

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Dugovic. Retrieved from https://idiyas.com/inventor/christine-dugovic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Dugovic: Innovator in Serotonin-Mediated Therapies

Introduction

Christine Dugovic is a notable inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmacology, particularly in the treatment of serotonin-mediated diseases. Her innovative approach combines different therapeutic strategies to enhance patient outcomes.

Latest Patents

Christine Dugovic holds 1 patent for her invention titled "Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy." This patent addresses the treatment of patients suffering from serotonin-mediated diseases or conditions, such as depression. The therapy involves administering an effective combined amount of a 5-HT7 receptor antagonist and a serotonin reuptake inhibitor, showcasing her commitment to improving mental health treatments.

Career Highlights

Christine is currently employed at Janssen Pharmaceutica NV, where she continues to work on innovative solutions in the pharmaceutical industry. Her role at this esteemed company allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Pascal Bonaventure and Curt A Dvorak. Their collaboration fosters a dynamic environment for innovation and research, enhancing the development of new therapies.

Conclusion

Christine Dugovic's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to serotonin-mediated therapies are paving the way for improved treatment options for patients suffering from depression and other related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…